Suvretta Capital Management’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.3M | Buy |
3,412,788
+1,075,292
| +46% | +$23.4M | 2.24% | 11 |
|
|
2025
Q1 | $43.2M | Buy |
2,337,496
+91,496
| +4% | +$1.69M | 1.6% | 17 |
|
|
2024
Q4 | $59.8M | Buy |
2,246,000
+400,838
| +22% | +$10.7M | 2.04% | 14 |
|
|
2024
Q3 | $43.4M | Buy |
1,845,162
+132,459
| +8% | +$3.11M | 1.39% | 25 |
|
|
2024
Q2 | $31.8M | Buy |
1,712,703
+148,994
| +10% | +$2.76M | 1.17% | 30 |
|
|
2024
Q1 | $27.9M | Buy |
+1,563,709
| New | +$27.9M | 1.04% | 31 |
|